Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-β

Abstract We developed an ELISA assay demonstrating the high prevalence of serum IgM to phosphatidylcholine (IgM-PC) in the first stages of multiple sclerosis (MS). We aimed to analyze the role of serum IgM-PC as a biomarker of response to treatment. Paired serum samples from 95 MS patients were obta...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Úrsula Muñoz, Cristina Sebal, Esther Escudero, Elena Urcelay, Rafael Arroyo, Maria A. García-Martínez, Francisco J. Quintana, Roberto Álvarez-Lafuente, Maria Cruz Sádaba
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2022-08-01
Edice:	Scientific Reports
On-line přístup:	https://doi.org/10.1038/s41598-022-16218-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!